News
FDA clears test to monitor residual disease in CML
The system can quantitate the molecular response of patients receiving tyrosine kinase inhibitor therapy.
News
Trametinib effectively treats case of giant congenital melanocytic nevus
Intractable pain and pruritus resolved completely, which contributed to dramatic improvements in quality of life.
News
Switching long-acting injectables deemed safe in schizophrenia
At 6 months, all-cause discontinuation was 30.4% and medication-related discontinuation was 9.2%
News
LGBTQ youth struggle in foster or unstable housing situations
Analyses assessed risks including problems with mental health issues, in school, and with substance use.
News
Impella RP shows higher mortality in postapproval study
These results are interim and the FDA is continuing to evaluating them.
News
New recall for CoaguChek test strips issued
These CoaguChek XS PT test strips were distributed by Terrific Care and Medex but weren’t included in Roche Diagnostics’ original recall.
News
FDA approves generic Advair Diskus
The approval hopefully will increase access for patients with asthma and COPD, according to the FDA.
News
Positive well-being may be ‘buffer against depression’ in adults with ASD
“These results are consistent with research in the general population that shows well-being functions as a buffer or protective factor against...
News
FDA: Clozapine REMS modified
Prescribers and pharmacies are required to be certified in the clozapine REMS program by Feb. 28.
News
Pembrolizumab approved for Merkel cell carcinoma
The FDA granted accelerated approval for the drug based on promising results in nonrandomized, open-label trial.
News
A case of cold burn reported with whole-body cryotherapy
A 71-year-old man presented with a cold burn injury a day after a cryotherapy session for back pain and arthritis.
News
Phase 3 study of novel pemphigus treatment is initiated
Results of a phase 2 study of the BTK inhibitor were positive.
News
Firdapse approved: First treatment for rare autoimmune disorder
Amifampridine (Firdapse) has been approved by the FDA for Lambert-Eaton myasthenic syndrome, which affects the nerves’ connection with muscles.